You are in: eMedicine Specialties > Sports Medicine > Hip Hip FractureArticle Last Updated: Dec 9, 2005AUTHOR AND EDITOR INFORMATIONAuthor: Naveenpal S Bhatti, MD, Consulting Staff, Department of Emergency Medicine, Hayward/Fremont Medical Centers Naveenpal S Bhatti is a member of the following medical societies: American College of Emergency Physicians Coauthor(s): Janos P Ertl, MD, Clinical Assistant Professor, Department of Orthopedic Surgery, University of California at Davis; Director of Amputee Clinic, Chief of Orthopedic Trauma, Kaiser Hospital Editors: Gerard A Malanga, MD, Founder and Director, New Jersey Sports Medicine Institute; Director of Pain Management, Overlook Hospital; Director of Sports Medicine, Sports Medicine Fellowship Director, Mountainside Hospital; Clinical Chief, Rehabilitation Medicine and Electrodiagnosis, St Michael's Medical Center; Medical Director, Consultant, Horizon Healthcare Worker's Compensation Services, Blue Cross and Blue Shield Worker's Compensation; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Henry T Goitz, MD, Chief, Sports Medicine, Associate Professor, Department of Orthopaedic Surgery, Medical College of Ohio; Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital; Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago Author and Editor Disclosure Synonyms and related keywords: femoral neck fracture, intracapsular hip fracture, hip stress fracture, femoral neck stress fracture, femoral stress fracture, Garden classification, Colonna classification, Evan classification, broken hip, fractured hip, cracked hip INTRODUCTIONBackgroundAlthough sports injuries to the knee, ankle, and shoulder have been well documented, injuries to the pelvis, hip, and thigh get little attention because of their low prevalence. Unfortunately, severe consequences may result if these injuries are improperly managed. Femoral neck stress fractures were mainly seen in military recruits due to a triad of activity that is new, strenuous, and highly repetitive. However, as a result of self-imposed fitness regimens of recreational athletes, over the last 20 years the number of these injuries has been increasing in nonmilitary populations. In contrast, contact sports such as football, rugby, and soccer are usually the cause of most fractures of the hip. Stress fractures occur in normal bone undergoing repeated submaximal stress. As the bone attempts to remodel, osteoclastic activity occurs at a greater rate than osteoblastic activity. When these cumulative forces exceed the structural strength of bone, stress fractures occur. Stress fractures occur mainly at the femoral neck and are classified as either tension (at the superior aspect of the femoral neck) or compression (at the inferior aspect of the femoral neck). Hip fractures are classified as intracapsular, which includes femoral head and neck fractures, or extracapsular, which includes trochanteric, intertrochanteric, and subtrochanteric fractures. The location of the fracture and the amount of angulation and comminution play integral roles in the overall morbidity of the patient, as does the preexisting physical condition of the individual. Fractures of the proximal femur are extremely rare in young athletes and are usually caused by high-energy motor vehicle accidents or significant trauma during athletic activity. Other causes may be an underlying disease process such as Gaucher disease, fibrous dysplasia, or bone cyst. Identification and initiation of treatment is imperative in attempts to avoid complications, such as avascular necrosis (AVN). AVN is more common in patients in the pediatric and adolescent age groups. This outcome is due to the precarious nature of the blood supply to the subchondral region of the femoral head, which does not stabilize until years after skeletal maturity, after which collateral flow develops. FrequencyUnited States
Functional AnatomyThe hip is a ball-and-socket joint composed of the acetabulum and the head of the femur. The femoral head is connected to the shaft by the femoral neck. These are supported by a network of trabecular bone. Two other important landmarks on the proximal femur are the greater and lesser trochanters. These 2 structures are the main muscle attachment sites for the proximal bone. The iliopsoas muscle is connected to the lesser trochanter, and the abductors and short rotator muscles act through their insertion on the greater trochanter. In addition, many additional muscles attach along the intertrochanteric line, and, along with the muscles, they bring with them an abundant and redundant blood supply, which is conducive to healing. This is in contrast to the intercapsular femoral neck, which is prone to healing complications. The blood supply to the femoral head has been studied extensively and has been found to change substantially during development. Until the cartilaginous growth plate forms a barrier at age 4 years, the major blood supply comes from the medial and lateral circumflex arteries (metaphyseal arteries), which arise from the deep femoral artery. After age 4 years, the posterosuperior and posteroinferior arterial branches of the medial femoral circumflex bypass the growth plate and form the main blood supply to the femoral head. During adolescence, the growth plate fuses and the metaphyseal vessels again become significant, traveling along the femoral neck. Fractures in this area can disrupt this delicate blood supply, leading to AVN, the most severe complication of this fracture. Sport Specific BiomechanicsThe ball-and-socket joint provides most of the inherent stability of the hip joint while allowing for a large range of motion. Additional stability is provided by the thick capsule and strong ligamentous structures that actually enforce the capsule, namely the iliofemoral, the pubofemoral, and the ischiofemoral ligaments. These ligaments are taut with internal rotation, which limits motion, and become lax with external rotation. Motion about the hip occurs in the sagittal, frontal, and transverse planes. During normal gait, motion occurs in all 3 planes, and normal activities occur within the range of 120° flexion, 20° extension, 40° abduction, 25° adduction, and 45° external and internal rotation. The biomechanics of the neck-shaft angle, which averages 135° and 10-15° of anteversion, allows for a unique arrangement. This permits angular movements of the thigh to be converted to rotatory hip motion. CLINICALHistoryPatients with hip fractures may present in a variety of ways, ranging from an 80-year-old woman reporting hip pain after a trivial fall to a 30-year-old man in hemorrhagic shock after a high-speed motor vehicle accident. Stress fractures usually manifest more insidiously, with an otherwise healthy person reporting pain related to activity and not healing with the conservative treatments suggested by their primary care doctor.
PhysicalFindings of the physical evaluation of the patient with a hip fracture may include the following:
CausesFactors such as muscle fatigue, (which leads to abnormal gait patterns and altered stress distribution), training errors, improper footwear, and poor training surfaces can predispose an athlete to the development of stress fractures. DIFFERENTIALSFemoral Head Avascular Necrosis Femoral Neck Fracture Femoral Neck Stress Fracture Femur Injuries and Fractures Hip Overuse Syndrome Hip Pointer Iliopsoas Tendinitis Slipped Capital Femoral Epiphysis
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Cefazolin (Ancef, Kefzol, Zolicef) |
|---|---|
| Description | First-generation semisynthetic cephalosporin that arrests bacterial cell wall synthesis, inhibiting bacterial growth. Primarily active against skin flora, including Staphylococcus aureus. Typically used alone for skin and skin-structure coverage. IV and IM dosing regimens are similar. |
| Adult Dose | 250 mg to 2 g IV/IM q6-12h depending on severity of infection; not to exceed 12 g/d |
| Pediatric Dose | 25-100 mg/kg/d IV/IM divided q6-8h depending on severity of infection; not to exceed 6 g/d |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid prolongs effect; coadministration with aminoglycosides may increase renal toxicity; may yield false-positive urine-dip test result for glucose |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal impairment; superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy |
| Drug Name | Tobramycin (Nebcin) |
|---|---|
| Description | Used in skin, bone, and skin-structure infections caused by S aureus, Pseudomonas aeruginosa, Proteus species, Escherichia coli, Klebsiella species, and Enterobacter species. Indicated in the treatment of staphylococcal infections when penicillin or potentially less toxic drugs are contraindicated and when bacterial susceptibility and clinical judgment justifies its use. |
| Adult Dose | Serious infection: 3 mg/kg/d IV/IM divided tid Life-threatening infections: 5 mg/kg/d IV/IM divided tid/qid, and reduce to 3 mg/kg/d as soon as clinically indicated; to prevent increased toxicity caused by excessive blood levels, do not exceed 5 mg/kg/d unless serum levels are monitored |
| Pediatric Dose | 6-7.5 mg/kg/d IV divided tid/qid (2-2.5 mg/kg q8h or 1.5-1.9 mg/kg q6h) |
| Contraindications | Documented hypersensitivity |
| Interactions | Increases effects of neuromuscular blockers and potentiates effect of extended-spectrum penicillins; concurrent administration with amphotericin B, cephalosporins, and loop diuretics increases risk of nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Avoid use in renal impairment, preexisting auditory or vestibular impairment, and in patients with neuromuscular disorders; aminoglycosides are associated with nephrotoxicity and ototoxicity |
| Drug Name | Ampicillin and sulbactam (Unasyn) |
|---|---|
| Description | Drug combination of beta-lactamase inhibitor with ampicillin. Covers skin, enteric flora, and anaerobes. Not ideal for nosocomial pathogens. |
| Adult Dose | 1.5 (1 g ampicillin + 0.5 g sulbactam) to 3 g (2 g ampicillin + 1 g sulbactam) IV/IM q 6-8h; not to exceed 4 g/d sulbactam or 8 g/d ampicillin |
| Pediatric Dose | 3 months to 12 years: 100-200 mg ampicillin/kg/d (150-300 mg Unasyn) IV divided q6h >12-years: Administer as in adults; not to exceed 4 g/d sulbactam or 8 g/d ampicillin |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction |
| Drug Name | Gentamicin (Gentacidin, Garamycin) |
|---|---|
| Description | Aminoglycoside antibiotic for gram-negative coverage. Used in combination with both an agent against gram-positive organisms and one that covers anaerobes. |
| Adult Dose | 1.5 mg/kg IV with 1-2 g ampicillin 30 min prior to procedure; not to exceed 80 mg |
| Pediatric Dose | 2 mg/kg IV with ampicillin (50 mg/kg) 30 min prior to procedure |
| Contraindications | Documented hypersensitivity; non–dialysis-dependent renal insufficiency |
| Interactions | Coadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular blocking agents, thus prolonged respiratory depression may occur; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly) |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment |
Pain control is essential to quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and have sedating properties, which are beneficial for patients who have sustained trauma or have sustained injuries.
| Drug Name | Morphine sulfate (Duramorph, Astramorph, MS Contin, MSIR, Oramorph) |
|---|---|
| Description | DOC for analgesia because of reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Various IV doses are used; commonly titrated until desired effect obtained. |
| Adult Dose | Starting dose: 0.1 mg/kg IV/IM/SC Maintenance dose: 5-20 mg/70 kg IV/IM/SC q4h Relatively hypovolemic patients: Start with 2 mg IV/IM/SC; reassess hemodynamic effects of dose |
| Pediatric Dose | Infants and children: 0.1-0.2 mg/kg dose IV/IM/SC q2-4h prn; not to exceed 15 mg/dose; may initiate at 0.05 mg/kg/dose |
| Contraindications | Documented hypersensitivity; hypotension; potentially compromised airway where establishing rapid airway control would be difficult |
| Interactions | Phenothiazines may antagonize analgesic effects of opiate agonists; TCAs, MAOIs, and other CNS depressants may potentiate adverse effects of morphine |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate |
| Drug Name | Ketorolac (Toradol) |
|---|---|
| Description | Inhibits prostaglandin synthesis by decreasing the activity cyclooxygenase, which results in decreased formation of prostaglandin precursors. |
| Adult Dose | 30-60 mg IM initially, followed by 15-30 mg q6h prn; not to exceed 5 d of treatment |
| Pediatric Dose | Not established; recommended dose is 0.4-1 mg/kg IM once |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding; do not administer into CNS |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts (rare) usually return to normal during ongoing therapy; discontinue therapy if persistent leukopenia, granulocytopenia, or thrombocytopenia occur |
As may be expected, each athlete is treated on an individual basis. The athlete should be off all pain medications, be relatively pain free, and have no return of symptoms during sports-specific activities.
Complications related to poorly treated or misdiagnosed stress fractures are considerable. AVN, nonunion, varus deformity, chronic pain, and completely displaced femoral neck fractures may occur and may lead to serious life-altering changes in function and the patient's ability to ambulate efficiently.
The prognosis for hip fractures is dependent on the age and condition of the patient and on the location and type of fracture. Athletes who sustain femoral neck stress fractures may or may not be able to return to their sport. Tension stress fractures are generally unstable and have an unfavorable prognosis. On the other hand, compression fractures are usually successfully treated with conservative measures and have a good prognosis for recovery. Hip fractures in elderly individuals have a mortality rate of 14-36% one year following surgery.
Patient education is a very important aspect to the rehabilitation process following hip fracture, regardless of the patient's age. Patients must thoroughly informed about treatment options following their diagnosis and must understand the benefits and risks of treatment. If conservative treatment is an option, the patient may need instruction in the use of crutches initially to restrict weight bearing. A physical therapist should be involved in the patient's care for instructions in mobility training and reconditioning of the affected lower extremity. Patients are usually instructed in a home exercise program for continuing strengthening of the hip so that they are able to return to their previous level of activity.
For excellent patient education resources, visit eMedicine's Breaks, Fractures, and Dislocations Center and Sports Injury Center. Also, see eMedicine's patient education article Total Hip Replacement.
| Media file 1: A subcapital femoral neck fracture. Slight compression of the femoral head onto the femoral neck can be seen. Note the cortical break medially. This fracture could be missed if not closely evaluated. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 2: A view of the contralateral hip for comparison. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 3: Intraoperative x-ray film (fluoroscopic view) of placement of the lag screw. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 4: Addition of a superior derotational screw to maintain alignment and allow compression. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 5: Internal fixation of the subcapital femoral neck fracture with a screw and short side plate with an additional derotational screw above. Final anteroposterior view. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 6: Garden I femoral neck fracture. Note the valgus impaction with compression of the superior femoral head-neck junction. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 7: Lateral view of a Garden I femoral neck fracture. Compression of the head-neck junction inferiorly. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 8: Anteroposterior view of the pelvis with a displaced femoral neck fracture. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 9: Lateral view of a displaced femoral neck fracture. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 10: Displaced femoral neck fracture treated with a conventional, noncemented monopolar hemiarthroplasty. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 11: Lateral view of a unipolar hemiarthroplasty. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 12: An example of a calcar replacement hemiarthroplasty. A low femoral neck fracture extending into the calcar femoralis, not amenable to internal fixation or conventional hemiarthroplasty, requiring a calcar replacement prosthesis. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 13: A lateral x-ray film of a calcar replacement hemiarthroplasty. | |
![]() | View Full Size Image | Media type: X-RAY |
Article Last Updated: Dec 9, 2005